Marpai, Inc. Receives Significant Investment
A Total of $1.7 Million Raised in Recent Quarter
Marpai, Inc. (OTCQX: MRAI), an innovative and independent Third-Party Administration (TPA) company, has announced an additional investment of $200,000 from HillCour Investment Fund, LLC. This funding comes as part of a new private placement of 147,058 shares of common stock at a price of $1.36 per share. The funding aims to bolster the company’s strategic initiatives focused on enhancing its technology platform and expanding its market reach among self-funded employer groups nationwide.
Commitment to Innovation
Damien Lamendola, Marpai’s CEO, expresses strong confidence in the company’s mission and products. He stated, "I continue to invest in Marpai because I believe in what we're building—smarter healthcare, better outcomes, and a scalable platform that's disrupting a massive market." Lamendola emphasizes that this investment reflects his deep commitment to ensuring the company's growth strategy leads to sustainable profitability.
Funding Usage and Expansion Plans
With the net proceeds from this investment, Marpai plans to focus on general corporate purposes that include accelerating the deployment of advanced product offerings and enhancing its technological capabilities. The funding also aims at deeper penetration in the ever-expanding market of self-funded health plans, showcasing Marpai's commitment to innovation and efficiency in healthcare delivery.
About Marpai, Inc.
Marpai, Inc. (OTCQX: MRAI) operates in the $150 billion TPA sector and the $550 billion Pharmacy Benefit Management industry. The company caters primarily to employers who self-fund their employee health benefits, handling trillions in annual claims. Marpai's unique approach emphasizes the importance of delivering healthier member populations through its signature initiative, Marpai Saves. This initiative not only aims to improve health outcomes but also to optimize health plan budgets. Marpai is committed to providing employer groups access to leading provider networks, including Cigna, thereby enhancing their service offerings in the competitive healthcare marketplace.
About HillCour Investment Fund
HillCour Investment Fund is primarily focused on high-growth, technology-driven companies that have the potential for disruptive market impact. Managed by Damien Lamendola, HillCour's involvement in Marpai signifies a strategic partnership aiming for mutual growth and innovation in the healthcare space.
Frequently Asked Questions
What is Marpai, Inc.?
Marpai, Inc. is a technology platform company providing Third-Party Administration services aimed at self-funded employer health plans.
What recent investment did Marpai receive?
Marpai received a $200,000 investment from HillCour Investment Fund, reinforcing its growth strategy and commitment to healthcare innovation.
Who is Damien Lamendola?
Damien Lamendola is the CEO of Marpai, Inc., and also manages HillCour Investment Fund, focusing on technology-driven companies.
How does Marpai aim to use the $200,000 investment?
The investment will be used for general corporate purposes, including product development and enhancing technological capabilities.
What are the main services offered by Marpai?
Marpai offers TPA services and health plan solutions aimed at improving healthcare outcomes for self-funded employers.
